Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.47% | 81.21 | 0.9% | $648.72m | |
| CELG | Celgene Corporation | -10.76% | 121.33 | 1.1% | $640.82m | |
| AMGN | Amgen Inc. | -0.63% | 182.96 | 1.1% | $453.41m | |
| BIIB | Biogen Inc. | -1.26% | 338.10 | 1.2% | $410.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.81% | 432.98 | 2.7% | $314.62m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.02% | 154.63 | 1.9% | $217.79m | |
| INCY | Incyte Corporation | -0.07% | 114.19 | 2.5% | $202.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.08% | 138.94 | 1.9% | $183.38m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.82% | 114.68 | 10.7% | $157.13m | |
| EXEL | Exelixis, Inc. | -1.06% | 27.17 | 6.5% | $135.00m | |
| ILMN | Illumina, Inc. | 2.29% | 209.88 | 3.5% | $132.21m | |
| BLUE | Bluebird Bio, Inc. | 2.22% | 142.55 | 17.3% | $118.24m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.43% | 87.75 | 4.4% | $113.37m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.41% | 51.94 | 16.9% | $108.74m | |
| CLVS | Clovis Oncology, Inc. | 0.95% | 77.50 | 16.5% | $103.06m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.